Clinical Trials Directory

Trials / Completed

CompletedNCT06566833

Effectiveness of Different Remineralizing Strategies on the Management of Early Carious Lesions in Primary Teeth

Effectiveness of Different Remineralizing Strategies on the Management of Early Carious Lesions in Primary Teeth (Randomized Controlled Clinical Trial)

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Accepted

Summary

the primary aim of the study is remineralization of early carious lesions in primary teeth using different remineralizing agents of different remineralizing strategies when applied in an intensive mode. The secondary aim of the study is to compare their antibacterial effect against streptococcus mutans and their effect on reducing the size of the lesions.

Detailed description

The primary aim of the study is to compare the effect of curodont repair fluoride plus (self-assembling peptide p11-4 with 0.5% sodium fluoride) with MI varnish (casein phosphopeptide amorphous calcium phosphate fluoride) and Colgate fluoride varnish (5% sodium fluoride) in remineralization of early carious lesions in primary anterior teeth. The study sample is consisted of 66 patients aged 3-6 years old with at least 2 white spot lesions in their primary anterior teeth who are assigned into control group (n=22): colgate fluoride varnish, test group 1(n=22): MI varnish and test group 2 (n=22) :curodont repair fluoride plus. Each material is applied once every 2 weeks for 3 times (intensive mode of application). The secondary aim of the study is to determine the antibacterial effect of each material against streptococcus mutans is compared by obtaining a plaque sample at baseline then after application by 48 hours, 1 months and 3 months and culturing using disk diffusion method for determining the log count of streptococcus mutans at each time point. Another secondary aim is to determine the change in lesion size at baseline and after 6 months and 12 months using standardized photographs with a digital camera.

Conditions

Interventions

TypeNameDescription
DRUGself assmbling peptide p11-4 combined with 0.05% fluoridebiomimetic remineralizing agent
DRUGCasein phosphopeptide amorphous calcium phosphateremineralizing agents that acts as a fluoride booster
DRUG5% sodium fluoride varnishremineralizing agent that is used as a gold standard for remineralization

Timeline

Start date
2023-08-15
Primary completion
2024-10-15
Completion
2024-10-15
First posted
2024-08-22
Last updated
2025-01-29

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT06566833. Inclusion in this directory is not an endorsement.